Skip to main content

and
  1. Article

    Open Access

    Downregulation of KEAP1 in melanoma promotes resistance to immune checkpoint blockade

    Immune checkpoint blockade (ICB) has demonstrated efficacy in patients with melanoma, but many exhibit poor responses. Using single cell RNA sequencing of melanoma patient-derived circulating tumor cells (CTCs...

    Douglas B. Fox, Richard Y. Ebright, **n Hong, Hunter C. Russell in npj Precision Oncology (2023)

  2. Article

    Open Access

    A post-transcriptional program of chemoresistance by AU-rich elements and TTP in quiescent leukemic cells

    Quiescence (G0) is a transient, cell cycle-arrested state. By entering G0, cancer cells survive unfavorable conditions such as chemotherapy and cause relapse. While G0 cells have been studied at the transcript...

    Sooncheol Lee, Douglas Micalizzi, Samuel S. Truesdell, Syed I. A. Bukhari in Genome Biology (2020)

  3. Article

    Open Access

    Blood-based monitoring identifies acquired and targetable driver HER2 mutations in endocrine-resistant metastatic breast cancer

    Plasma genoty** identifies potentially actionable mutations at variable mutant allele frequencies, often admixed with multiple subclonal variants, highlighting the need for their clinical and functional vali...

    Arielle J. Medford, Taronish D. Dubash, Dejan Juric, Laura Spring in npj Precision Oncology (2019)

  4. No Access

    Article

    Expression of the NF-κB-responsive gene BTG2 is aberrantly regulated in breast cancer

    BTG2, a p53-inducible antiproliferative gene, is stimulated in breast cancer cells by activation of nuclear factor kappa B (NF-κB). In rat mammary glands, BTG2 is expressed in epithelial cells and levels decrease...

    Hirofumi Kawakubo, Jennifer L Carey, Elena Brachtel, Vandana Gupta in Oncogene (2004)

  5. No Access

    Article

    BRCA1 and GADD45 mediated G2/M cell cycle arrest in response to antimicrotubule agents

    BRCA1 is a tumour suppressor gene implicated in the predisposition to early onset breast and ovarian cancer. We have generated cell lines with inducible expression of BRCA1 to evaluate its role in mediating th...

    Paul B Mullan, Jennifer E Quinn, Paula M Gilmore, Stewart McWilliams in Oncogene (2001)

  6. No Access

    Article

    E1B 55K sequesters WT1 along with p53 within a cytoplasmic body in adenovirus-transformed kidney cells

    WT1 encodes a tumor suppressor that is expressed in cells of the develo** kidney and is inactivated in Wilms tumor, a pediatric kidney cancer. The adenovirus E1B 55K gene product contributes to the transformati...

    Shyamala Maheswaran, Christoph Englert, Sean Bong Lee, Robert M Ezzel in Oncogene (1998)

  7. No Access

    Article

    The EWS-WT1 translocation product induces PDGFA in desmoplastic small round-cell tumour

    Chromosomal translocations resulting in chimaeric transcription factors underlie specific malignancies, but few authentic target genes regulated by these fusion proteins have been identified. Desmoplastic smal...

    Sean Bong Lee, Kathryn Ann Kolquist, Kim Nichols, Christoph Englert in Nature Genetics (1997)

  8. No Access

    Article

    The Wilms tumour gene WT1 is expressed in murine mesoderm–derived tissues and mutated in a human mesothelioma

    The tumour suppressor gene WT1 encodes a transcription factor expressed in tissues of the genito–urinary system. Inactivation of this gene is associated with the development of Wilms tumour a pediatric kidney ...

    Seon Park, Martin Schalling, Amy Bernard, Shyamala Maheswaran in Nature Genetics (1993)